Skip to main content
All lobbying filings

MCDERMOTT+

Lobbying for PATIENTS FOR AFFORDABLE DRUGS NOW · non-partisan national patient organization fighting to lower drug prices

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 8, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 7
  • JULIA GRABO
    Previously held: 2021: Paid Intern, Rep. Colin Allred
  • DEBRA CURTIS
    Previously held: 1998-2013: Legislative Director, Chief of Staff, Rep. Pete Stark; jointly Professional Staff on Committee on Ways and Means, Health Subcommittee
  • RODNEY WHITLOCK
    Previously held: 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood
  • AMY KELBICK
    Previously held: 2015-2017: Senior Policy Advisor, Rep. Jan Schakowsky; 2013-2015: Senior Legislative Assistant, Rep. Bill Foster; 2009-2013: Legislative Assistant, Staff Assistant, Rep. Maurice Hinchey
  • JOSH JORGENSEN New on this filing
    Previously held: 2017-2020: Senior Legislative Correspondent; Legislative Aide, Sen. Mike Rounds
  • MADALYN NEWS
    Previously held: 2020: Paid Intern, Rep. Madeleine Dean
  • ERIN ELIZABETH FULLER New on this filing
    Previously held: 2020: Paid Intern, Rep. Elissa Slotkin

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 3
Health Issues

Issues related to prescription drug competition and pricing.

Consumer Issues/Safety/Products

Issues related to prescription drug competition and pricing.

Medicare/Medicaid

Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem